- Home
- WALD vs STXS Comparison
WALD vs STXS Comparison
Compare WALD & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- STXS
- Stock Information
- Founded
- WALD 1988
- STXS 1990
- Country
- WALD United States
- STXS United States
- Employees
- WALD N/A
- STXS N/A
- Industry
- WALD Package Goods/Cosmetics
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WALD Consumer Discretionary
- STXS Health Care
- Exchange
- WALD Nasdaq
- STXS Nasdaq
- Market Cap
- WALD 306.3M
- STXS 261.1M
- IPO Year
- WALD 2021
- STXS 2004
- Fundamental
- Price
- WALD $1.83
- STXS $2.88
- Analyst Decision
- WALD Strong Buy
- STXS
- Analyst Count
- WALD 5
- STXS 0
- Target Price
- WALD $4.96
- STXS N/A
- AVG Volume (30 Days)
- WALD 527.9K
- STXS 442.3K
- Earning Date
- WALD 11-11-2025
- STXS 11-10-2025
- Dividend Yield
- WALD N/A
- STXS N/A
- EPS Growth
- WALD N/A
- STXS N/A
- EPS
- WALD N/A
- STXS N/A
- Revenue
- WALD $273,868,000.00
- STXS $31,806,000.00
- Revenue This Year
- WALD $10.37
- STXS $30.92
- Revenue Next Year
- WALD $14.37
- STXS $43.27
- P/E Ratio
- WALD N/A
- STXS N/A
- Revenue Growth
- WALD 25.55
- STXS 33.94
- 52 Week Low
- WALD $1.48
- STXS $1.54
- 52 Week High
- WALD $4.40
- STXS $3.05
- Technical
- Relative Strength Index (RSI)
- WALD 52.51
- STXS 58.78
- Support Level
- WALD $1.66
- STXS $2.81
- Resistance Level
- WALD $1.79
- STXS $2.92
- Average True Range (ATR)
- WALD 0.13
- STXS 0.10
- MACD
- WALD 0.04
- STXS -0.01
- Stochastic Oscillator
- WALD 81.40
- STXS 74.14
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.